Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wouter Jukema

Showing results (191-200 of 927) with videos related to

Pageof 93
Sort By:
Circulation|August 27, 2003
Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatinRobert Kleemann, Hans M G Princen, Jef J Emeis, et al.
European Heart Journal|August 2, 2011
A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?Jeffrey J W Verschuren, Stella Trompet, Judith A M Wessels, et al.
International Journal of Cardiology|February 5, 2008
Coronary collaterals improve prognosis in patients with ischemic heart diseaseJakub J Regieli, J Wouter Jukema, Hendrik M Nathoe, et al.
Current Medical Research and Opinion|November 26, 2005
LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) studyJ Wouter Jukema, An-Ho Liem, Peter H J M Dunselman, et al.
Diabetes Care|November 18, 2009
Increased carotid intima-media thickness as a predictor of the presence and extent of abnormal myocardial perfusion in type 2 diabetesRoxana Djaberi, Joanne D Schuijf, J Wouter Jukema, et al.
BMC Ophthalmology|June 16, 2023
Effect of alirocumab on cataracts in patients with acute coronary syndromesGaspard Suc, Gregory G Schwartz, Shaun G Goodman, et al.
The International Journal of Cardiovascular Imaging|November 6, 2003
End-diastolic and end-systolic volume from the left ventricular angiogram: how accurate is visual frame selection? Comparison between visual and semi-automated comnputer-assisted analysisEva M Staal, Martine de Heer, J Wouter Jukema, et al.
International Journal of Cancer|June 30, 2026
Asymptomatic Cardiotoxicity After High-Dose Anthracycline Treatment in Sarcoma Patients Assessed by Biomarkers and EchocardiographyElissa A S Polomski, Frank M Speetjens, J Wouter Jukema, et al.
Current Medical Research and Opinion|January 30, 2008
The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO studyHenk W O Roeters van Lennep, An Ho Liem, Peter H J M Dunselman, et al.
JACC. Basic to Translational Science|March 26, 2025
EPA Induces an Anti-Inflammatory Transcriptome in T Cells, Implicating a Triglyceride-Independent Pathway in Cardiovascular Risk ReductionNathalie A Reilly, Koen F Dekkers, Jeroen Molenaar, et al.
Pageof 93

Showing results (191-200 of 927) with videos related to

Sort By:
Pageof 93
Circulation|August 27, 2003
Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatinRobert Kleemann, Hans M G Princen, Jef J Emeis, et al.
European Heart Journal|August 2, 2011
A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?Jeffrey J W Verschuren, Stella Trompet, Judith A M Wessels, et al.
International Journal of Cardiology|February 5, 2008
Coronary collaterals improve prognosis in patients with ischemic heart diseaseJakub J Regieli, J Wouter Jukema, Hendrik M Nathoe, et al.
Current Medical Research and Opinion|November 26, 2005
LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) studyJ Wouter Jukema, An-Ho Liem, Peter H J M Dunselman, et al.
Diabetes Care|November 18, 2009
Increased carotid intima-media thickness as a predictor of the presence and extent of abnormal myocardial perfusion in type 2 diabetesRoxana Djaberi, Joanne D Schuijf, J Wouter Jukema, et al.
BMC Ophthalmology|June 16, 2023
Effect of alirocumab on cataracts in patients with acute coronary syndromesGaspard Suc, Gregory G Schwartz, Shaun G Goodman, et al.
The International Journal of Cardiovascular Imaging|November 6, 2003
End-diastolic and end-systolic volume from the left ventricular angiogram: how accurate is visual frame selection? Comparison between visual and semi-automated comnputer-assisted analysisEva M Staal, Martine de Heer, J Wouter Jukema, et al.
International Journal of Cancer|June 30, 2026
Asymptomatic Cardiotoxicity After High-Dose Anthracycline Treatment in Sarcoma Patients Assessed by Biomarkers and EchocardiographyElissa A S Polomski, Frank M Speetjens, J Wouter Jukema, et al.
Current Medical Research and Opinion|January 30, 2008
The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO studyHenk W O Roeters van Lennep, An Ho Liem, Peter H J M Dunselman, et al.
JACC. Basic to Translational Science|March 26, 2025
EPA Induces an Anti-Inflammatory Transcriptome in T Cells, Implicating a Triglyceride-Independent Pathway in Cardiovascular Risk ReductionNathalie A Reilly, Koen F Dekkers, Jeroen Molenaar, et al.
Pageof 93